In their seminal works, Wang-Johanning et al. not only described HERV-K Env protein overexpression in breast cancer (39) but also showed that treatment with specific anti-HERV-K-Env-protein monoclonal antibodies is able to induce apoptosis in malignant cells and to reduce tumor growth (14). Here, ERVW-1 is linked to breast cancer.